PMID: 9545226May 9, 1998Paper

Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus

Science
T NakagawaA Y Rudensky

Abstract

Degradation of invariant chain (Ii) is a critical step in major histocompatibility complex class II-restricted antigen presentation. Cathepsin L was found to be necessary for Ii degradation in cortical thymic epithelial cells (cTECs), but not in bone marrow (BM)-derived antigen-presenting cells (APCs). Consequently, positive selection of CD4+ T cells was reduced. Because different cysteine proteinases are responsible for specific Ii degradation steps in cTECs and BM-derived APCs, the proteolytic environment in cells mediating positive and negative selection may be distinct. The identification of a protease involved in class II presentation in a tissue-specific manner suggests a potential means of manipulating CD4+ T cell responsiveness in vivo.

References

Nov 20, 1987·Science·P Marrack, J Kappler
Jan 1, 1995·Advances in Immunology·P J Fink, M J Bevan
Jan 1, 1994·Annual Review of Immunology·V H Engelhard
Jan 1, 1995·Annual Review of Cell and Developmental Biology·P R Wolf, H L Ploegh

❮ Previous
Next ❯

Citations

Jan 29, 2002·European Journal of Immunology·Esther B E PlügerChristoph Driessen
Jan 29, 2002·Journal of Cellular Biochemistry·Derek T JaneMichael J Dufresne
Jul 9, 1998·Protein Science : a Publication of the Protein Society·M E McGrathJ R Somoza
Jun 8, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Uta SchurigtRolf Bräuer
Jul 16, 2008·Marine Biotechnology·Steven RobertsFrederick Goetz
Mar 29, 2012·Immunologic Research·Konstantina Alexandropoulos, Nichole M Danzl
Dec 31, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Ke-Jin Hu, Pak-Chow Leung
Mar 18, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Izabela Berdowska
Jan 22, 2004·Current Opinion in Immunology·Paula Bryant, Hidde Ploegh
Sep 19, 2003·International Journal for Parasitology·S Hartmann, R Lucius
Feb 13, 2001·Immunology Letters·M A McGargill, K A Hogquist
Mar 19, 1999·Immunology Today·C ViretC A Janeway
Aug 11, 2000·Neuroscience Letters·Y YoshiyamaT Hattori
Jun 1, 2000·Experimental Gerontology·T von Zglinicki
Jan 13, 2001·Current Opinion in Immunology·C Watts
Jan 16, 2002·Current Opinion in Immunology·Ana-Maria Lennon-DuménilCécile Lagaudrière-Gesbert
Feb 19, 2000·Current Opinion in Immunology·R J Riese, H A Chapman
Mar 14, 2000·Current Opinion in Immunology·L Klein, B Kyewski
Apr 5, 2003·Molecular and Cellular Neurosciences·Masato KoikeYasuo Uchiyama
Mar 15, 2000·The International Journal of Biochemistry & Cell Biology·R I BrinkworthJ P Dalton
May 19, 2001·International Immunopharmacology·M T Harrison, K L McCoy
Mar 18, 2003·International Immunopharmacology·Timothy A Gondre-LewisKathleen L McCoy
Oct 3, 2003·Ageing Research Reviews·Hiroshi Nakanishi
Oct 20, 2010·Immunology and Cell Biology·Nathalie LabrecqueSylvie Lesage
Jul 24, 2007·Nature Cell Biology·Min YangGuo-Ping Shi
Jun 21, 2013·Nature Communications·Eleni AdamopoulouChristina Stoeckle
Jul 21, 2010·Nature Immunology·Andrea C Carpenter, Rémy Bosselut
Sep 20, 2007·Nature Immunology·Peter E Jensen
Jan 25, 2005·Nature Medicine·Carmen UrbichStefanie Dimmeler
Nov 10, 2007·Nature Reviews. Immunology·Graham AndersonEric J Jenkinson
Nov 26, 2009·Nature Reviews. Immunology·Ludger KleinBruno Kyewski
Oct 8, 1999·The Biochemical Journal·K Sol-ChurchR W Mason
Mar 29, 2002·Immunology·John H Robinson, Alexei A Delvig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.